Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 1.32B | -10.83%1.37B | -22.75%5.88B | -26.00%1.48B | -29.70%1.54B | -16.28%7.61B | -28.96%1.6B | -19.81%1.81B | -11.91%2B | -4.67%2.19B |
| Cost of revenue | 15.7M | 126.24%18.54M | -84.69%48.5M | -86.26%11.77M | -94.17%8.19M | -25.37%316.87M | -91.90%9M | -25.68%81.58M | -17.16%85.64M | 40.09%140.67M |
| Gross profit | 1.3B | -11.57%1.35B | -20.06%5.83B | -23.30%1.47B | -25.28%1.53B | -15.84%7.29B | -25.70%1.6B | -19.51%1.73B | -11.66%1.91B | -6.72%2.05B |
| Operating expense | 1.26B | -3.45%1.26B | -48.92%5.15B | -56.21%1.25B | -65.18%1.31B | -17.18%10.09B | -61.79%1.31B | -27.68%2.17B | -2.99%2.85B | 33.55%3.76B |
| Selling and administrative expenses | --1.26B | -3.58%1.26B | -48.99%5.16B | -57.25%1.25B | -62.88%1.31B | -17.36%10.11B | -57.52%1.47B | -27.42%2.18B | -0.52%2.93B | 24.88%3.53B |
| -General and administrative expense | --1.26B | -3.58%1.26B | -48.99%5.16B | -57.25%1.25B | -62.88%1.31B | -17.36%10.11B | -57.52%1.47B | -27.42%2.18B | -0.52%2.93B | 24.88%3.53B |
| Other operating expenses | --588K | -85.87%383K | -97.10%11.54M | --118K | -98.89%2.71M | 30,745.97%397.91M | 16,598.10%175.33M | 3,398.77%2.83M | ---- | 940,115.38%244.46M |
| Total other operating income | --1.15M | -93.01%299K | -96.82%13.22M | -94.54%4.34M | -72.87%4.28M | 720.89%416.15M | 1,044.38%333.49M | 446.03%12.18M | 1,025.15%79.41M | 28.60%15.77M |
| Operating profit | 39.79M | -59.51%89.72M | 124.06%673.63M | 123.62%220.58M | 112.95%221.59M | 20.47%-2.8B | 122.31%285.64M | 48.33%-440.01M | -21.42%-933.88M | -176.33%-1.71B |
| Net non-operating interest income (expenses) | 387.26M | -64.49%60.2M | 3.79%435.84M | -26.10%124.78M | 102.76%169.56M | 5,024.63%419.92M | 516.97%47.7M | 361.90%119.77M | 1,679.46%168.84M | 113.57%83.62M |
| Non-operating interest income | --277.31M | -54.93%77.08M | 4.13%443.12M | -26.10%126.2M | 100.94%171.02M | 156.10%425.55M | 830.78%48.15M | 138.64%121.52M | 112.16%170.77M | 105.86%85.11M |
| Non-operating interest expense | ---109.95M | 1,054.17%16.87M | 29.43%7.28M | -26.48%1.42M | -1.55%1.46M | -96.78%5.62M | -90.64%454K | -98.19%1.75M | -97.27%1.94M | -32.10%1.49M |
| Net investment income | ||||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | ||||||||||
| Other non-operating income (expenses) | ||||||||||
| Income before tax | 427.04M | -61.67%149.92M | 146.62%1.11B | 145.14%345.36M | 124.03%391.14M | 32.56%-2.38B | 125.80%333.34M | 64.31%-320.24M | -0.71%-765.05M | -180.56%-1.63B |
| Income tax | -74.56M | 3,602.64%38.53M | -47.76%-222.99M | -233.34%-10.38M | -124.29%-1.1M | -337.35%-150.92M | -884.93%-162.72M | -104.35%-510K | -57.02%7.78M | -65.20%4.53M |
| Net income | 501.61M | -71.60%111.4M | 159.78%1.33B | 146.03%355.74M | 124.03%392.24M | 37.96%-2.23B | 137.79%496.06M | 64.83%-319.73M | 0.64%-772.83M | -175.17%-1.63B |
| Net income continuous operations | --501.61M | -71.60%111.4M | 159.78%1.33B | 146.03%355.74M | 124.03%392.24M | 37.96%-2.23B | 137.79%496.06M | 64.83%-319.73M | 0.64%-772.83M | -175.17%-1.63B |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | 501.61M | -71.60%111.4M | 159.78%1.33B | 146.03%355.74M | 124.03%392.24M | 36.10%-2.23B | 137.79%496.06M | 64.83%-319.73M | -6.49%-772.83M | -201.88%-1.63B |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 501.61M | -71.60%111.4M | 159.78%1.33B | 146.03%355.74M | 124.03%392.24M | 36.10%-2.23B | 137.79%496.06M | 64.83%-319.73M | -6.49%-772.83M | -201.88%-1.63B |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 6.37 | -67.78%1.35 | 167.13%15.58 | 151.45%4.25 | 126.64%4.19 | 30.65%-23.21 | 139.05%4.92 | 60.78%-3.42 | -18.68%-8.26 | -203.67%-15.73 |
| Diluted earnings per share | 6.37 | -67.78%1.35 | 167.10%15.58 | 151.40%4.25 | 126.62%4.19 | 30.63%-23.2191 | 139.05%4.92 | 60.78%-3.42 | -18.80%-8.2684 | -203.27%-15.7376 |
| Dividend per share | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |